<DOC>
	<DOCNO>NCT00090025</DOCNO>
	<brief_summary>The main purpose study determine XL119 effective combination 5-fluorouracil ( 5FU ) leucovorin ( LV ) prolong survival subject advance biliary tumor .</brief_summary>
	<brief_title>XL119 Versus 5-Fluorouracil ( 5-FU ) Plus Leucovorin ( LV ) Subjects With Advanced Biliary Tumors</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Male female subject advance histologically confirm biliary cancer ( gallbladder cancer cholangiocarcinoma ) amenable conventional surgical approach 18 year old Life expectancy least 12 week Eastern Cooperative Oncology Group ( ECOG ) Performance Status score le 3 Willing able sign inform consent Sexually active men woman must use accepted effective method contraception ( include barrier contraception spermicide ) Women childbearing age must negative pregnancy test Laboratory criterion Prior chemotherapy ( exclude chemotherapy give adjuvant treatment complete 6 month prior entry study ) Unstable angina , class III IV New York Heart Association heart disease Central nervous system metastasis Uncontrolled diabetes mellitus Uncontrolled seizure disorder Major surgery , chemotherapy , immunotherapy , radiotherapy 28 day precede first study treatment Need concomitant anticancer therapy ( chemotherapy , immunotherapy , radiation ) investigational agent study participation 28 day prior study participation Pregnant breastfeed A known history human immunodeficiency virus ( HIV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Advanced Biliary Cancer</keyword>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Gall bladder tumor</keyword>
	<keyword>Gall bladder cancer</keyword>
	<keyword>Bile duct tumor</keyword>
	<keyword>Tumor biliary tree</keyword>
</DOC>